-
Listing
-
CSD
European CSD modelBuilding the CSD of Choice in EuropeLees meerEuronext Securities is shaping the future of European capital markets by enhancing integration, connectivity, and innovation.
-
Technology
Euronext Technology SolutionsHigh-Frequency Trading Solution (HFTS)Lees meerThe new generation of high-frequency risk trading platforms, offering the highest performance with ultra-low latency and minimal jitter, all at a low total cost of ownership.
-
Data
-
Indices
Thematic indicesNew indicesLees meerThematic European Indices on Energy Security, Strategic Autonomy and Aerospace & Defence
- Reglementen
-
About Euronext
Euronext strategic planInnovate for Growth 2027Lees meerShaping capital markets for future generations
-
Listing
-
CSD
European CSD modelBuilding the CSD of Choice in EuropeLees meerEuronext Securities is shaping the future of European capital markets by enhancing integration, connectivity, and innovation.
-
Technology
Euronext Technology SolutionsHigh-Frequency Trading Solution (HFTS)Lees meerThe new generation of high-frequency risk trading platforms, offering the highest performance with ultra-low latency and minimal jitter, all at a low total cost of ownership.
-
Data
-
Indices
Thematic indicesNew indicesLees meerThematic European Indices on Energy Security, Strategic Autonomy and Aerospace & Defence
- Reglementen
-
About Euronext
Euronext strategic planInnovate for Growth 2027Lees meerShaping capital markets for future generations
- Home
- About
- Media centre
- Bell en Gong Archief
- IPO Inventiva
IPO Inventiva
15/02/2017
Listing of Inventiva on Euronext
Frédéric Cren, Chairman and CEO and Co-Founder of Inventiva, opens the trading day in Paris.
Inventiva specializes in the research and development of therapeutic products for the treatment of Parkinson's disease, cancer, autoimmune diseases and fibrosis.
At the end of 2015, the company has a portfolio of five products, including 3 in pre-clinical development phase and 2 in clinical development.